Francisco Javier Álvarez-Gutiérrez

7PUBLICATIONS
22CO-AUTHORS
Epidemiological modellingPharmaceutical delivery technologiesMedical molecular engineering of nucleic acids and proteinsAllergyEngineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Effect of Delayed Initiation of Mepolizumab on EXACTO Scale Scores, Clinical Remission SEPAR-REMAS Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study.

|May 04, 2026
Peak Inspiratory Flow Capability for Simulated Dry Powder Inhaler Resistances in Asthma Patients Prescribed Pressurized Metered-Dose Inhalers with Valved Holding Chambers: The USE-DPI Study.

|Feb 19, 2026
Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria.

Antonio Leon Lloreda, Belen Muñoz-Sánchez, David Echavarria Kashmiri

|Nov 19, 2024
Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus).

Juan Carlos Miralles-López, Francisco J Alvarez-Gutiérrez, Julio Delgado-Romero

|Jun 01, 2022
Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma.

Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, Julio Delgado Romero

|Feb 25, 2021
Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study.

Francisco Javier Alvarez-Gutiérrez, Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo

Pageof 2

Frequent Collaborators

2 joint publications

Antonio León-Lloreda

1 joint publications

Santiago Quirce

1 joint publications

Jose Gregorio Soto-Campos

1 joint publications

Ruben Andújar-Espinosa